Skadden advised Theravance Biopharma, while Goodwin Procter advised Royalty Pharma on the deal. Willkie Farr & Gallagher advised Innoviva on the sale of its stake in...
You must be a Standard 1 Year member to access this content.
Willkie Farr & Gallagher advised Innoviva on the transaction. Innoviva, Inc., a diversified holding company with a portfolio of royalties and a growing portfolio of innovative...
You must be a Standard 1 Year member to access this content.
Willkie Farr & Gallagher LLP represented Innoviva in the transaction, while Kirkland & Ellis advised GlaxoSmithKline. Innoviva, Inc. (NASDAQ: INVA) executed definitive agreement to purchase Glaxo...
You must be a Standard 1 Year member to access this content.
